AVROBIO, Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update

Author's Avatar
Aug 09, 2018
Article's Main Image

Completes IPO, initiates Phase 2 clinical trial in Fabry disease, expands board of directors